Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia diseaseMohammad Khosravi, Morteza Karimipoor|European Journal of Pharmacology|2019Cited by 68